Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 17, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

Lymphadenectomy with robotic cystectomy.

John W Davis¹, Ashish M Kamat

¹The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. johndavis@mdanderson.org

Current Urology Reports

|November 10, 2012

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bladder Preservation After Neoadjuvant Therapy for Muscle-invasive Bladder Cancer in the Current Era: Myth and Reality.

European urology focus·2025

Same author

Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group.

European urology oncology·2025

Same author

Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder Cancer.

European urology oncology·2025

Same author

Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer.

European urology·2025

Same author

Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.

The oncologist·2025

Same author

Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder.

European urology·2025

Experienced robotic surgeons can achieve high-quality pelvic lymph node dissection during robot-assisted radical cystectomy. Recent data show advancements in urinary diversion and complication reporting, maintaining oncologic outcomes while reducing patient morbidity.

Area of Science:

Urology
Surgical Oncology
Robotic Surgery

Background:

Robot-assisted radical cystectomy (RRC) is a standard treatment for invasive bladder cancer.
Pelvic lymph node dissection (PLND) is crucial for accurate staging and oncologic outcomes in RRC.
Ensuring the quality of PLND during RRC is essential for patient management.

Purpose of the Study:

To establish the quality of extended template pelvic lymph node dissection (ETPLND) performed by experienced robotic surgeons during RRC.
To report recent advancements in robot-assisted urinary diversion and cost-effectiveness.
To present standardized complication reporting for RRC.

Main Methods:

Comparative analysis of lymph node counts, positive lymph node rates, and oncologic outcomes in N1 patients undergoing RRC with ETPLND.

Related Experiment Videos

Last Updated: May 17, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

Review of recent data on robot-assisted urinary diversion techniques.

Evaluation of cost-focused studies and standardized complication reporting metrics.

Main Results:

Established evidence supports high-quality ETPLND by experienced robotic surgeons during RRC.
Adequate lymph node dissections are maintained with advancements in surgical techniques.
Recent data indicate progress in robot-assisted urinary diversion and complication standardization.

Conclusions:

Experienced robotic surgeons can perform high-quality ETPLND during RRC.
Ongoing research focuses on improving robot-assisted urinary diversion and cost-effectiveness.
These advancements aim to reduce patient morbidity associated with radical cystectomy for invasive disease.